Seeing Is Believing

Currently out of the existing stock ratings of Mark Marcon, 95 are a BUY (63.76%), 54 are a HOLD (36.24%).
Analyst Mark Marcon, currently employed at BAIRD, carries an average stock price target met ratio of 58.42% that have a potential upside of 17.82% achieved within 207 days.
Mark Marcon’s has documented 312 price targets and ratings displayed on 20 stocks. The coverage is on Healthcare, Industrials, Technology sectors.
Most recent stock forecast was given on PYCR, Paycor HCM at 06-Feb-2025.
Analyst best performing recommendations are on HQY (HEALTHEQUITY).
The best stock recommendation documented was for HQY (HEALTHEQUITY) at 3/18/2020. The price target of $47 was fulfilled within 6 days with a profit of $6.46 (15.93%) receiving and performance score of 26.56.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$120
$23.5 (24.35%)
$100
21 days ago
(07-Oct-2025)
7/8 (87.5%)
$27.91 (30.31%)
408
Buy
$126
$29.5 (30.57%)
$125
1 months 26 days ago
(02-Sep-2025)
7/10 (70%)
$30.46 (31.88%)
133
Buy
$125
$28.5 (29.53%)
$125
1 months 26 days ago
(02-Sep-2025)
21/25 (84%)
$29.46 (30.84%)
176
Buy
$134
$37.5 (38.86%)
$130
1 months 26 days ago
(02-Sep-2025)
9/11 (81.82%)
$38.46 (40.26%)
396
Buy
$115
$18.5 (19.17%)
$103
4 months 24 days ago
(04-Jun-2025)
17/18 (94.44%)
$2.3 (2.04%)
198
What Year was the first public recommendation made by Mark Marcon?